Comparison of Poly-L-lactic Acid and Calcium Hydroxylapatite for Treating Human Immunodeficiency Virus&#150Associated Facial Lipoatrophy

Article Type
Article
Changed
Thu, 01/10/2019 - 12:43
Display Headline
Comparison of Poly-L-lactic Acid and Calcium Hydroxylapatite for Treating Human Immunodeficiency Virus–Associated Facial Lipoatrophy
Author(s)
Schweiger ES
Riddle CC
Wernli BJ
Tonkovic-Capin V

Article PDF
020050304.pdf
Author and Disclosure Information

Schweiger ES, Riddle CC, Wernli BJ, Tonkovic-Capin V

Issue
Cutis - 79(5)
Publications
Cutis
MDedge Dermatology
Topics
Aesthetic Dermatology
Page Number
304-312
Sections
From the Cosmetic Dermatology Archives
Author(s)
Schweiger ES
Riddle CC
Wernli BJ
Tonkovic-Capin V
Author(s)
Schweiger ES
Riddle CC
Wernli BJ
Tonkovic-Capin V
Author and Disclosure Information

Schweiger ES, Riddle CC, Wernli BJ, Tonkovic-Capin V

Author and Disclosure Information

Schweiger ES, Riddle CC, Wernli BJ, Tonkovic-Capin V

Article PDF
020050304.pdf
Article PDF
020050304.pdf

Issue
Cutis - 79(5)
Issue
Cutis - 79(5)
Page Number
304-312
Page Number
304-312
Publications
Cutis
MDedge Dermatology
Publications
Cutis
MDedge Dermatology
Topics
Aesthetic Dermatology
Article Type
Article
Display Headline
Comparison of Poly-L-lactic Acid and Calcium Hydroxylapatite for Treating Human Immunodeficiency Virus–Associated Facial Lipoatrophy
Display Headline
Comparison of Poly-L-lactic Acid and Calcium Hydroxylapatite for Treating Human Immunodeficiency Virus–Associated Facial Lipoatrophy
Sections
From the Cosmetic Dermatology Archives
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media
Subscribe to Wernli BJ